Overview Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: In combination with chemotherapy, with the procedure of Grownup clients with regionally recurrent unresectable or metastatic triple-unfavorable breast most cancers who've not acquired prior chemotherapy for metastatic illness and whose tumours Specific programmed cel